CIK 0000885590 · Large accelerated filer
Bausch Health Companies Inc.
Sign in to watch- Ticker
- BHC
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- operating
- Phone
- 514-744-6792
- Business address
- 2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
- Former names
- Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
- 4 Grant or award Director acquired 3,673 shares (grant or award)
- 4 Grant or award Director acquired 1,065 shares (grant or award)
- 4 Planned sale EVP, General Counsel sold 13,370 shares at $7.31 ($97,735)
- 4 Open-market sale Director sold 15,912 shares at $7.66 ($121,886)
- 4 Open-market buy Director bought 34,721,118 shares at $9.00 ($312,490,062)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 3,243,049 shares at an average $6.56 ($21,267,731)
- 4 Grant or award Director acquired 30,149 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 30,149 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award EVP, US Pharma acquired 30,847 shares (grant or award)
- 4 Shares withheld for taxes EVP, US Pharma gave up 22,736 shares (to pay taxes)
- 4 Grant or award SVP, Controller & CAO acquired 27,371 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 9,384 shares (grant or award)
- 4 Grant or award Director acquired 4,034 shares (grant or award)
- 4 Grant or award Director acquired 1,032 shares (grant or award)
- 4 Open-market buy Director bought 3,564,059 shares at $5.94 ($21,170,510)
- 4 Open-market buy Director bought 2,788,608 shares at an average $5.27 ($14,700,257)
Page 3 of 61 · 1,214 filings